Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3762321010 | Erythromycin ethyl succinate 200 mg chewable tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3762322015 | Product containing precisely erythromycin ethylsuccinate 200 milligram/1 each conventional release chewable tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3762323013 | Erythromycin ethylsuccinate 200 mg chewable tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely erythromycin ethylsuccinate 200 milligram/1 each conventional release chewable tablet (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 1 | |
| Product containing precisely erythromycin ethylsuccinate 200 milligram/1 each conventional release chewable tablet (clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| Product containing precisely erythromycin ethylsuccinate 200 milligram/1 each conventional release chewable tablet (clinical drug) | est un(e) (attribut) | Erythromycin only product in oral dose form | true | Inferred relationship | Some | ||
| Product containing precisely erythromycin ethylsuccinate 200 milligram/1 each conventional release chewable tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely erythromycin ethylsuccinate 200 milligram/1 each conventional release chewable tablet (clinical drug) | Has precise active ingredient | Erythromycin ethylsuccinate | true | Inferred relationship | Some | 1 | |
| Product containing precisely erythromycin ethylsuccinate 200 milligram/1 each conventional release chewable tablet (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 1 | |
| Product containing precisely erythromycin ethylsuccinate 200 milligram/1 each conventional release chewable tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely erythromycin ethylsuccinate 200 milligram/1 each conventional release chewable tablet (clinical drug) | Has presentation strength numerator value (attribute) | 200 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely erythromycin ethylsuccinate 200 milligram/1 each conventional release chewable tablet (clinical drug) | Has basis of strength substance (attribute) | Erythromycin ethylsuccinate | true | Inferred relationship | Some | 1 | |
| Product containing precisely erythromycin ethylsuccinate 200 milligram/1 each conventional release chewable tablet (clinical drug) | Plays role | Antibacterial therapeutic role (role) | true | Inferred relationship | Some | ||
| Product containing precisely erythromycin ethylsuccinate 200 milligram/1 each conventional release chewable tablet (clinical drug) | est un(e) (attribut) | Erythromycin-containing product in oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely erythromycin ethylsuccinate 200 milligram/1 each conventional release chewable tablet (clinical drug) | a pour principe actif (attribut) | Erythromycin ethylsuccinate | false | Inferred relationship | Some | ||
| Product containing precisely erythromycin ethylsuccinate 200 milligram/1 each conventional release chewable tablet (clinical drug) | a une forme pharmaceutique (attribut) | comprimé | false | Inferred relationship | Some | ||
| Product containing precisely erythromycin ethylsuccinate 200 milligram/1 each conventional release chewable tablet (clinical drug) | a pour principe actif (attribut) | Bactericide | false | Inferred relationship | Some | ||
| Product containing precisely erythromycin ethylsuccinate 200 milligram/1 each conventional release chewable tablet (clinical drug) | a une forme pharmaceutique (attribut) | forme orale | false | Inferred relationship | Some | ||
| Product containing precisely erythromycin ethylsuccinate 200 milligram/1 each conventional release chewable tablet (clinical drug) | est un(e) (attribut) | Erythromycin ethyl succinate | false | Inferred relationship | Some | ||
| Product containing precisely erythromycin ethylsuccinate 200 milligram/1 each conventional release chewable tablet (clinical drug) | a une forme pharmaceutique (attribut) | Oral tablet | false | Inferred relationship | Some | ||
| Product containing precisely erythromycin ethylsuccinate 200 milligram/1 each conventional release chewable tablet (clinical drug) | a une forme pharmaceutique (attribut) | Chewable tablet | true | Inferred relationship | Some | ||
| Product containing precisely erythromycin ethylsuccinate 200 milligram/1 each conventional release chewable tablet (clinical drug) | est un(e) (attribut) | Medicinal product containing macrolide and acting as antibacterial agent (product) | false | Inferred relationship | Some | ||
| Product containing precisely erythromycin ethylsuccinate 200 milligram/1 each conventional release chewable tablet (clinical drug) | est un(e) (attribut) | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR